CUT | XLB | CUT / XLB | |
Gain YTD | -6.243 | 0.978 | -638% |
Net Assets | 46.1M | 4.97B | 1% |
Total Expense Ratio | 0.74 | 0.08 | 925% |
Turnover | 32.00 | 13.00 | 246% |
Yield | 3.26 | 2.02 | 162% |
Fund Existence | 18 years | 26 years | - |
CUT | XLB | |
---|---|---|
RSI ODDS (%) | 2 days ago81% | 2 days ago81% |
Stochastic ODDS (%) | 2 days ago81% | 2 days ago84% |
Momentum ODDS (%) | 2 days ago83% | 2 days ago83% |
MACD ODDS (%) | 2 days ago84% | 2 days ago85% |
TrendWeek ODDS (%) | 2 days ago82% | 2 days ago85% |
TrendMonth ODDS (%) | 2 days ago80% | 2 days ago81% |
Advances ODDS (%) | 2 days ago83% | 2 days ago86% |
Declines ODDS (%) | 4 days ago82% | 4 days ago85% |
BollingerBands ODDS (%) | 5 days ago90% | 5 days ago90% |
Aroon ODDS (%) | 2 days ago83% | 2 days ago77% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VKI | 8.52 | 0.06 | +0.71% |
Invesco Advantage Municipal Income Trust II | |||
ECF | 9.46 | 0.03 | +0.32% |
Ellsworth Growth and Income Fund Ltd | |||
MDEV | 19.90 | N/A | N/A |
First Trust Indxx Global Mdcl Dvcs ETF | |||
IBDW | 20.55 | -0.02 | -0.10% |
iShares iBonds Dec 2031 Term Corp ETF | |||
GNOM | 7.50 | -0.18 | -2.30% |
Global X Genomics & Biotechnology ETF |
A.I.dvisor indicates that over the last year, XLB has been closely correlated with LIN. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLB jumps, then LIN could also see price increases.